GH releasing peptides - structure and kinetics

Journal of Pediatric Endocrinology and Metabolism

Volumn 6, Issue 1, 1993, Pages 21-32

  Bowers, C Y ^a  

^a TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; GROWTH HORMONE RELEASING PEPTIDE; GROWTH HORMONE RELEASING PEPTIDE 1; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; OLIGOPEPTIDE; PRALMORELIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG ADMINISTRATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FLUSHING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RASH; SUBCUTANEOUS DRUG ADMINISTRATION; SWEATING;

ADMINISTRATION, ORAL; ADULT; AMINO ACID SEQUENCE; CHILD; COMPARATIVE STUDY; DRUG SYNERGISM; FEMALE; GROWTH HORMONE; HUMAN; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RADIOIMMUNOASSAY; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0027180817     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.1993.6.1.21     Document Type: Article

References (32)

1. Momany F, Bowers CY, Reynolds GA, Hong A, Newlander K. Conformational energy studies and in vitro activity data on active GH releasing peptides. Endocrinology 1984; 114: 1531–1536.
2. Bowers CY, Momany F, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984; 14: 1537–1545.
3. Bowers CY, Alster DK, Frentz JM. The GH releasing activity of a synthetic hexapeptide in normal men and short stature children after oral administration. J Clin Endocrinol Metab 1992; 74: 292–298.
4. Mericq V, Cassorla F, Garcia H, Avila A, Merriam GR. Growth hormone responses to a second-generation growth hormone releasing peptide and to GH-releasing hormone (GHRH) in growth hormone deficient children. (abst) In: Program Endocrine Society, 74th Annual Meeting, San Antonio, TX, June 1992, p. 171.
5. 2, act on different pituitary receptors to release GH. (abs) In: Program Endocrine Society, 67th Annual Meeting, Baltimore, MD, June 1985, p. 38.
6. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989; 124: 2791–2798.
7. Codd EE, Shu AYL, Walker RF. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary sites. Neuropharmacology 1989; 28: 1139–1144.
8. Sethumadahavan K, Veeraragavan K, Bowers CY. Demonstration and characterization of the specific binding of growth hormone-releasing peptide (GHRP) to rat anterior pituitary and hypothalamic membranes. Biochem Biophys Res Comm 1991; 178: 31–37.
9. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991; 128: 2027–2035.
10. Clark RG, Carlsson LMS, Trohnar J, Robinson ICAF. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anesthetized rats. J Neuroendocrinol 1989; 1: 249–255.
11. Goth MI, Lyons CE, Canny BJ, Thorner MO. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992; 130: 939–944.
12. 2 induced growth hormone release from rat primary pituitary cells. Endocrinology 1991; 129: 3337–3342.
13. Bercu BB, Weideman CA, Walker RF. Sex differences in growth hormone (GH) secretion by rats administered GH-releasing hexapeptide. Endocrinology 1991; 129: 2592–2598.
14. Walker RF, Yang SW, Bercu BB. Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH). Life Sci 1991; 49: 1499–1504.
15. Koch BD, Blalock JB, Schonbrunn A, Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. L An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin. J Biol Chem 1988; 263: 216–225.
16. 2) and other secretagogues in rat somatotrophs. (abs) In: Program Endocrine Society, 74th Annual Meeting, San Antonio, TX, June 1992, p. 255.
17. Chik CL, Akman M, Girard M, Ho AK. Growth hormone releasing peptide stimulates GH via a calcium-dependent cAMP-independent mechanism. (abst) In: Program Endocrine Society, 74th Annual Meeting, San Antonio, TX, June 1992, p. 182.
18. 2 stimulate growth hormone release through distinct receptor sites. J Endocrinol 1991; 129: 11–19.
19. 2, (GHRP-6) in the rat. Endocrinology 1985; 117: 1441–1447.
20. 2 in rat primary pituitary cell monolayer culture. Endocrinology 1985; 116: 952–957.
21. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab 1989; 69: 212–214.
22. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990; 70: 975–982.
23. Bowers CY, Reynolds GA, Barrera CM. A second generation GH releasing heptapeptide. (abst) In: Program Endocrine Society, 73rd Annual Meeting, Washington, D.C., June 1991, 422.
24. Bowers CY, Newell D, Granda-Ayala R, Garcia M, Barrera C. Comparative studies on GH release in younger and older men and women. (abst) In: Program Endocrine Society, 74th Annual Meeting, San Antonio, TX, June 1992, p. 172.
25. Hartman ML, Farello G, Pezzoli SS, Thorner MO. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. J Clin Endocrinol Metab 1992; 74: 1378–1384.
26. 2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men. Endocrinol Japon 1991; 38: 15–21.
27. Ilson BE, Audet PR, Selvaggio AM, Jorkasky DK. Intranasal SK…F 110679 growth hormone releasing peptide stimulates growth hormone secretion in young adult men. (abst) In: Program Endocrine Society, 73rd Annual Meeting, D.C., June 1991, 84.
28. DeBell WK, Pezzoli SS, Thorner MO. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation. J Clin Endocrinol Metab 1991; 72: 1312–1316.
29. Jaffe CA, Ho PJ, Demott Friberg R, Bowers CY, Barkan AL. Effect of prolonged growth hormone releasing peptide infusion on GH secretion in normal men. (abst) In: Program Endocrine Society, 74th Annual Meeting, San Antonio, TX, June 1992, 169.
30. Huhn WC, Hartman ML, Pezzoli SS, Thorner MO. 24-hour continuous growth hormone releasing peptide (GHRP, SK…F 110679) augments pulsatile growth hormone (GH) secretion and selectively attenuates the response to a subsequent GHRP bolus. (abst) In: Program Endocrine Society, 74th Annual Meeting, San Antonio, TX, June 1992, p. 169.
31. Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone releasing factor from a human pancreatic islet tumor. Nature 1982; 300: 276–278.
32. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982; 218: 585–587.